LetopCS® small molecule glucosamine chondroitin is derived from natural chondroitin sulfate and utilizes a globally leading patented enzymatic hydrolysis process to precisely break down traditional large molecule chondroitin sulfate into small molecules ranging from 500-1000Da, closely resembling the natural structure of the human body. This greatly enhances its bioavailability. Its absorption efficiency is 158 times higher than that of conventional chondroitin, easily crossing the intestinal barrier and rapidly reaching the joint area for repair.
Scientific validation shows:
158 times improved absorption efficiency, quickly absorbed by the body.
Within 7 days, joint pain reduced by 43.5%, stiffness improved by 54.3%, and support strength increased by 68.78%.
Dual mechanism: Inhibits inflammation factors such as IL-1β and TNF-α, and promotes the synthesis of type II collagen and glycosaminoglycans, repairing joint structure.
LetopCS® small molecule glucosamine chondroitin provides precise intervention and scientific maintenance for joint health, helping consumers easily manage joint issues and restore flexible, comfortable joint movement.